Home › Funds › Clearbridge Investments, LLC › CVS

Clearbridge Investments, LLC position in CVS

CVS HEALTH CORP · Consumer Staples

Clearbridge Investments, LLC reported holding 8,188,869 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$701.7M, representing 0.61% of its reported portfolio and ranking #33 among its reported holdings. Clearbridge Investments, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)8.19M sh
Reported value held$701.70M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Clearbridge Investments, LLC's CVS position evolved

Clearbridge Investments, LLC first disclosed a stake in CVS in Q3 2023 at 749,116 shares (US$52.3M). The position peaked in Q2 2026 at 8,536,952 shares, worth US$883.1M. Across 13 filings, Clearbridge Investments, LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 8,188,869 shares valued at US$701.7M — a reduction of -348,083 shares quarter over quarter.. Notable position changes include a 307% increase in Q4 2023 (shares rose 2% over the following quarter), a 74% increase in Q4 2024 (shares rose 53% over the following quarter), a 93% increase in Q1 2025 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 749.12K $52.30M New
Q4 2023 3.05M $240.53M Add
Q1 2024 3.92M $313.01M Add
Q2 2024 2.52M $149.10M Reduce
Q3 2024 2.52M $158.77M Hold
Q4 2024 4.40M $197.39M Add
Q1 2025 8.48M $574.65M Add
Q2 2025 9.13M $629.70M Add
Q3 2025 9.03M $680.89M Reduce
Q4 2025 8.79M $697.69M Reduce
Q1 2026 8.77M $630.17M Hold
Q2 2026 8.54M $883.12M Reduce
Q3 2026 8.19M $701.70M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has Clearbridge Investments, LLC held CVS?

Clearbridge Investments, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Clearbridge Investments, LLC's current position in CVS?

As of Q3 2026, Clearbridge Investments, LLC holds 8.19M shares of CVS (CVS HEALTH CORP), valued at $701.70M, representing 0.61% of its reported portfolio and ranking #33.

Has Clearbridge Investments, LLC been buying or selling CVS?

In the latest 13F filing (Q3 2026), Clearbridge Investments, LLC reduced its position in CVS. The position peaked in Q2 2026 at 8.54M shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.